GW Pharmaceuticals Market Cap 2013-2019 | GWPH
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $3.265B | $0.013B |
GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and neuropathic pain. It operates primarily in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $152.034B | 27.73 |
Medtronic (MDT) | Ireland | $150.632B | 20.81 |
Stryker (SYK) | United States | $74.735B | 25.13 |
Boston Scientific (BSX) | United States | $62.262B | 29.39 |
Baxter (BAX) | United States | $42.637B | 25.85 |
Essilor Luxottica (ESLOY) | France | $33.791B | 0.00 |
Zimmer Biomet Holdings (ZBH) | United States | $30.320B | 19.02 |
Terumo (TRUMY) | Japan | $26.378B | 32.92 |
Lonza Group Ag (LZAGY) | Switzerland | $25.349B | 0.00 |
Coloplast (CLPBY) | Denmark | $25.034B | 38.63 |
ResMed (RMD) | United States | $21.891B | 40.38 |
Smith & Nephew SNATS (SNN) | United Kingdom | $19.633B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $19.217B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $10.857B | 52.11 |
Insulet (PODD) | United States | $10.712B | 509.65 |
William Demant Holdings (WILYY) | Denmark | $7.626B | 0.00 |
DiaSorin S.p.A (DSRLF) | Italy | $7.616B | 0.00 |
Perrigo (PRGO) | Ireland | $7.422B | 13.84 |
Canopy Growth (CGC) | Canada | $7.365B | 0.00 |
Hill-Rom Holdings (HRC) | United States | $7.342B | 21.65 |
Haemonetics (HAE) | United States | $5.938B | 40.13 |
Shandong Weigao Medical Polymer (SHWGF) | China | $5.472B | 0.00 |
GN STORE NORD (GNNDY) | Denmark | $5.276B | 27.26 |
NuVasive (NUVA) | United States | $3.844B | 30.27 |
ICU Medical (ICUI) | United States | $3.765B | 24.54 |
Neogen (NEOG) | United States | $3.625B | 60.65 |
Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.174B | 0.00 |
Quidel (QDEL) | United States | $2.995B | 28.42 |
Aurora Cannabis (ACB) | Canada | $2.833B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $2.691B | 0.00 |
National Vision Holdings (EYE) | United States | $2.513B | 56.71 |
Cardiovascular Systems (CSII) | United States | $1.557B | 0.00 |
Aphria (APHA) | $1.326B | 0.00 | |
InMode (INMD) | Israel | $1.245B | 0.00 |
AtriCure (ATRC) | United States | $1.217B | 0.00 |
VAREX IMAGING (VREX) | United States | $1.208B | 24.20 |
Phibro Animal Health (PAHC) | United States | $0.994B | 18.61 |
TG Therapeutics (TGTX) | United States | $0.935B | 0.00 |
NanoString Technologies (NSTG) | United States | $0.916B | 0.00 |
Lantheus Holdings (LNTH) | United States | $0.810B | 20.23 |
Eagle Pharmaceuticals (EGRX) | United States | $0.809B | 30.96 |
LeMaitre Vascular (LMAT) | United States | $0.707B | 39.75 |
Quanterix (QTRX) | United States | $0.698B | 0.00 |
PetIQ (PETQ) | United States | $0.694B | 16.94 |
Omeros (OMER) | United States | $0.657B | 0.00 |
HEXO (HEXO) | $0.573B | 0.00 | |
Cerus (CERS) | United States | $0.566B | 0.00 |
Surmodics (SRDX) | United States | $0.549B | 57.11 |
MacroGenics (MGNX) | United States | $0.505B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.491B | 29.48 |
Meridian Bioscience (VIVO) | United States | $0.418B | 14.38 |
Organigram Holdings (OGI) | Canada | $0.401B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.395B | 28.63 |
Owens & Minor (OMI) | United States | $0.387B | 14.30 |
BioLife Solutions (BLFS) | United States | $0.317B | 129.08 |
Zynex (ZYXI) | United States | $0.283B | 32.04 |
Neptune Wellness Solutions (NEPT) | Canada | $0.281B | 0.00 |
Bovie Medical (APYX) | United States | $0.275B | 0.00 |
United Health Products (UEEC) | United States | $0.254B | 0.00 |
Vapotherm (VAPO) | United States | $0.245B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.239B | 25.14 |
Repro-Med Systems (KRMD) | United States | $0.234B | 0.00 |
Green Organic Dutchman Holdings (TGODF) | Canada | $0.170B | 0.00 |
Liberty Health Sciences (LHSIF) | Canada | $0.170B | 0.00 |
InfuSystems Holdings (INFU) | United States | $0.164B | 824.00 |
Female Health (VERU) | United States | $0.156B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.145B | 0.00 |
MTech Acquisition (KERN) | United States | $0.136B | 0.00 |
Fonar (FONR) | United States | $0.131B | 9.20 |
Cytosorbents (CTSO) | United States | $0.130B | 0.00 |
Chimerix (CMRX) | United States | $0.118B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
United-Guardian (UG) | United States | $0.091B | 23.03 |
Chembio Diagnostics (CEMI) | United States | $0.078B | 0.00 |
Nephros (NEPH) | United States | $0.067B | 0.00 |
MRI Interventions (MRIC) | United States | $0.062B | 0.00 |
Surface Oncology (SURF) | United States | $0.050B | 0.00 |
ImmuCell (ICCC) | United States | $0.038B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.024B | 0.00 |
Senestech (SNES) | United States | $0.015B | 0.00 |
Valeritas Holdings (VLRX) | United States | $0.015B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.014B | 0.00 |
Conatus Pharmaceuticals (CNAT) | United States | $0.012B | 0.00 |
Myomo (MYO) | United States | $0.008B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.005B | 0.00 |
NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |